Inhibition of liver metastasis in mice by blocking hepatocyte lectins with arabinogalactan infusions and D-galactose

J Cancer Res Clin Oncol. 1987;113(1):51-5. doi: 10.1007/BF00389966.

Abstract

According to our hypothesis, organ-specific lectins (e.g., the D-galactose-specific hepatic binding protein) play an important role in the organ location of metastatic malignant cells. The rapid clearance and uptake by the liver of tritiated alpha 1-acid-(asialo)glycoprotein from the circulation of Balb/c mice was markedly delayed after preinjection of D-galactose or arabinogalactan. The preinjection (1 h) and regular application (for 3 days after tumor cell inoculation in Balb/c mice) of the receptor blocking agents D-galactose and arabinogalactan prevented the settling of sarcoma L-1 tumor in the liver completely, but did not influence the settling in the lung. Other galactans, dextrans, and phosphate-buffered saline showed no effect. Therefore, when lectins were blocked with competitive-specific glycoconjugates, colonization was prevented.

MeSH terms

  • Animals
  • Asialoglycoprotein Receptor*
  • Asialoglycoproteins / metabolism
  • Carrier Proteins / antagonists & inhibitors*
  • Galactans / pharmacology
  • Galactose / pharmacology
  • Lectins / antagonists & inhibitors
  • Liver Neoplasms / prevention & control
  • Liver Neoplasms / secondary*
  • Mice
  • Mice, Inbred BALB C
  • Neoplasm Metastasis*
  • Sarcoma, Experimental / pathology*

Substances

  • Asialoglycoprotein Receptor
  • Asialoglycoproteins
  • Carrier Proteins
  • Galactans
  • Lectins
  • hepatic sialoglycoprotein receptor
  • arabinogalactan
  • Galactose